CWR Weekly Recall Recap: April 14th-20th, 2026
Weekly update on hemp and cannabis recalls around the country.
CWR Weekly Recall Recap: April 7-13, 2026
Weekly update on hemp and cannabis recalls around the country.
CWR Weekly Recall Recap: Week of March 30 – April 6, 2026
Weekly update on hemp and cannabis recalls around the country.
CWR Weekly Recall Recap: Week of March 24–30, 2026
6 States. 8 Recalls. THC at 133x the Legal Limit. A Lab That Lied for Two Years. And Untested Flower at Nine Ohio Dispensaries.
A Peek Inside the Hidden Financial Backing of Curaleaf by a Putin-Linked Oligarch
Over $225 million from Roman Abramovich – routed through offshore shell companies in the British Virgin Islands – quietly built the foundation of Curaleaf.
Cannabis Vape Recall: Minnesota Product Had 40% THC, Labeled as 0.3%
Minnesota just recalled Tidal Wave vapes after testing found up to 40% THC in products labeled as containing less than 0.3%. Same week, Colorado issued its eighth cannabis recall of 2026. This is a product safety problem the industry isn’t talking about loudly enough.
What Cannabis Consumers Need to Know: Lab Shopping and Testing Fraud
From moldy flower to pesticide-laced vapes, “lab shopping” is putting us all at risk. Learn what this means, how to shop smarter, and how to report shady brands in your state using our Resources by State map.
A 2025 Wake-Up Call for QUALITY in Cannabis
Ensure your cannabis products meet the highest standards with transparent, accountable testing. Manipulated data and pay-to-pass testing compromise safety, quality, and industry growth.
CWR Founder, Stacey Watrobski voices concern about lack of standards and workplace hazards at CRA Quarterly Meeting September 11, 2024
View this post on Instagram A post shared by Stacey (@staceofbase_85) You can watch the public meeting full
Protecting Your Investment: The Hazards of Bioaerosols in Cannabis Facilities and How to Mitigate Them
Protecting cannabis workers from airborne hazards in the workplace, like bioaerosols, is crucial as the industry expands across the country. Bioaerosols, including fungal spores, bacteria, and plant material, pose significant respiratory risks in indoor cultivation and manufacturing facilities. Risks to workers also mean risks to consumers, also making this a public health concern.